Horizon Kinetics Medical ETF (MEDX)
NASDAQ: MEDX · Real-Time Price · USD
33.50
-0.22 (-0.64%)
At close: Dec 5, 2025, 4:00 PM EST
33.50
0.00 (0.00%)
After-hours: Dec 5, 2025, 4:15 PM EST
MEDX Holdings Information
MEDX is an equity ETF with a total of 35 individual holdings. The top holdings are Eli Lilly and Company stock at 16.98%, AbbVie at 8.75%, US BANK MMDA - USBGFS 7 at 8.46%, Novartis AG ADR at 6.33%, and Alnylam Pharmaceuticals at 5.75%.
Total Holdings
25
Top 10 Percentage
69.71%
Asset Class
Equity
ETF Category
Health
Assets
19.27M
PE Ratio
21.21
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 16.98% |
| 2 | ABBV | AbbVie Inc. | 8.75% |
| 3 | n/a | US BANK MMDA - USBGFS 7 | 8.46% |
| 4 | NVSN.MX | Novartis AG ADR | 6.33% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.75% |
| 6 | AZN | AstraZeneca PLC | 5.15% |
| 7 | IONS | Ionis Pharmaceuticals, Inc. | 5.09% |
| 8 | JNJ | Johnson & Johnson | 4.85% |
| 9 | BMY | Bristol-Myers Squibb Company | 4.34% |
| 10 | AMGN | Amgen Inc. | 4.00% |
| 11 | MRK | Merck & Co., Inc. | 3.38% |
| 12 | ALKS | Alkermes plc | 3.36% |
| 13 | PFE | Pfizer Inc. | 3.32% |
| 14 | CRSP | CRISPR Therapeutics AG | 3.06% |
| 15 | BIIB | Biogen Inc. | 2.83% |
| 16 | GSK | GSK plc | 2.73% |
| 17 | REGN | Regeneron Pharmaceuticals, Inc. | 2.59% |
| 18 | GALT | Galectin Therapeutics Inc. | 1.69% |
| 19 | BEAM | Beam Therapeutics Inc. | 1.38% |
| 20 | REPL | Replimune Group, Inc. | 0.76% |
| 21 | NTLA | Intellia Therapeutics, Inc. | 0.70% |
| 22 | SDZNY | Sandoz Group AG | 0.68% |
| 23 | VNDA | Vanda Pharmaceuticals Inc. | 0.67% |
| 24 | HLN | Haleon plc | 0.67% |
| 25 | LTRN | Lantern Pharma Inc. | 0.54% |
As of Dec 4, 2025